Total Payments
$481.06
2023 Payments
$13.47
Companies
7
Transactions
15
Medicare Patients
15,668
Medicare Billing
$989,369
Payment Breakdown by Category
Food & Beverage$329.66 (68.5%)
Travel$108.00 (22.5%)
Education$43.40 (9.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $329.66 | 12 | 68.5% |
| Travel and Lodging | $108.00 | 1 | 22.5% |
| Education | $43.40 | 2 | 9.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $149.90 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $132.69 | 7 | $0 (2018) |
| BIOTRONIK INC. | $108.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $43.40 | 2 | $0 (2022) |
| Shockwave Medical, Inc | $22.02 | 1 | $0 (2021) |
| Exact Sciences Corporation | $13.47 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $11.58 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.47 | 1 | Exact Sciences Corporation ($13.47) |
| 2022 | $193.30 | 4 | E.R. Squibb & Sons, L.L.C. ($149.90) |
| 2021 | $22.02 | 1 | Shockwave Medical, Inc ($22.02) |
| 2018 | $38.83 | 2 | Novartis Pharmaceuticals Corporation ($38.83) |
| 2017 | $213.44 | 7 | BIOTRONIK INC. ($108.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Oncology | ||||||
| 12/06/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 09/20/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/23/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| 05/25/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2021 | Shockwave Medical, Inc | Vascular Lithotripsy (Device) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Lithoplasty | ||||||
| 09/17/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/19/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/15/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/17/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/26/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/31/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/22/2017 | BIOTRONIK INC. | — | Travel and Lodging | In-kind items and services | $108.00 | General |
| 01/19/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,980 | 5,924 | $1.0M | $246,407 |
| 2022 | 40 | 3,557 | 5,642 | $1.0M | $243,184 |
| 2021 | 42 | 4,348 | 6,472 | $1.1M | $287,474 |
| 2020 | 41 | 3,783 | 5,330 | $859,311 | $212,305 |
Total Patients
15,668
Total Services
23,368
Medicare Billing
$989,369
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 607 | 973 | $381,416 | $90,726 | 23.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 168 | 176 | $112,112 | $24,268 | 21.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 387 | 396 | $91,872 | $20,781 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 92 | $50,692 | $12,509 | 24.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 190 | $43,824 | $12,316 | 28.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 639 | 939 | $50,706 | $10,195 | 20.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 552 | 908 | $24,543 | $5,967 | 24.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 67 | 69 | $24,012 | $5,892 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $21,568 | $5,668 | 26.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 53 | 82 | $20,859 | $5,210 | 25.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 27 | 28 | $20,389 | $4,799 | 23.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 112 | 281 | $23,323 | $4,679 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 74 | $20,572 | $4,423 | 21.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 70 | 70 | $17,500 | $4,224 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 40 | $13,584 | $3,920 | 28.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 77 | 185 | $18,315 | $3,885 | 21.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 33 | 36 | $12,564 | $3,182 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $11,960 | $3,136 | 26.2% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 73 | 280 | $10,360 | $2,406 | 23.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 50 | 58 | $7,432 | $2,349 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 242 | $2,904 | $2,033 | 70.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 35 | 78 | $9,516 | $2,029 | 21.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 14 | 20 | $6,760 | $1,550 | 22.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 73 | 73 | $5,110 | $1,243 | 24.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 12 | 62 | $5,394 | $1,215 | 22.5% |
About Dr. Jarvis Lambert, MD
Dr. Jarvis Lambert, MD is a Cardiovascular Disease healthcare provider based in Fall River, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518969708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jarvis Lambert, MD has received a total of $481.06 in payments from pharmaceutical and medical device companies, with $13.47 received in 2023. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($329.66).
As a Medicare-enrolled provider, Lambert has provided services to 15,668 Medicare beneficiaries, totaling 23,368 services with total Medicare billing of $989,369. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Fall River, MA
- Active Since 06/01/2005
- Last Updated 04/22/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518969708
Products in Payments
- ENTRESTO (Drug) $132.69
- CAMZYOS (Drug) $125.00
- VERQUVO (Drug) $43.40
- Vascular Lithotripsy (Device) $22.02
- Cologuard Collection Kit (Device) $13.47
- XARELTO (Drug) $11.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fall River
Bassem Nasser, M.d, M.D
Cardiovascular Disease — Payments: $21,799
Cardiovascular Disease $21,799
Zia Kidwai, M.d, M.D
Cardiovascular Disease — Payments: $20,287
Cardiovascular Disease $20,287
Ravi Chander, M.d, M.D
Cardiovascular Disease — Payments: $12,959
Cardiovascular Disease $12,959
Dr. Ann Grady, M.d, M.D
Cardiovascular Disease — Payments: $8,932
Cardiovascular Disease $8,932
Dr. M. Wajid Baig, Md, MD
Cardiovascular Disease — Payments: $2,608
Cardiovascular Disease $2,608
Peter Mandelson, Md, MD
Cardiovascular Disease — Payments: $1,186
Cardiovascular Disease $1,186